The Cardiovascular Risk of Proton Pump Inhibitors and the Dangers of Polypharmacy.
Citation: Mayo Clinic Proceedings. 96(10):2511-2513, 2021 10.PMID: 34607632Institution: MedStar Heart & Vascular Institute | MedStar Washington Hospital CenterDepartment: Cardiovascular Disease FellowshipForm of publication: Journal ArticleMedline article type(s): EditorialSubject headings: *Cardiovascular Diseases | *Proton Pump Inhibitors | Cardiovascular Diseases/ci [Chemically Induced] | Cardiovascular Diseases/ep [Epidemiology] | Heart Disease Risk Factors | Humans | Polypharmacy | Proton Pump Inhibitors/ae [Adverse Effects] | Risk FactorsYear: 2021ISSN:- 0025-6196
Item type | Current library | Collection | Call number | Status | Date due | Barcode |
---|---|---|---|---|---|---|
Journal Article | MedStar Authors Catalog | Article | 34607632 | Available | 34607632 |
English